Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 171,200 | 313,100 | 65,100 | 365,700 | 147,500 |
| Receivables | 465,200 | 489,400 | 470,200 | 453,000 | 451,700 |
| Inventories | 1,871,300 | 1,819,100 | 1,764,300 | 1,763,000 | 1,733,700 |
| Other current assets | 279,100 | 294,100 | 258,900 | 320,900 | 295,000 |
| TOTAL | $2,786,800 | $2,915,700 | $2,558,500 | $2,902,600 | $2,627,900 |
| Non-Current Assets | |||||
| PPE Net | 808,300 | 790,600 | 781,400 | 787,900 | 769,700 |
| Investments And Advances | 53,200 | 50,600 | 53,000 | 51,500 | 48,600 |
| Intangibles | 4,813,700 | 4,762,600 | 4,807,400 | 4,879,100 | 4,874,800 |
| Other Non-Current Assets | 48,000 | 44,200 | 60,900 | 55,000 | 83,700 |
| TOTAL | $5,723,200 | $5,648,000 | $5,702,700 | $5,773,500 | $5,776,800 |
| Total Assets | $8,510,000 | $8,563,700 | $8,261,200 | $8,676,100 | $8,404,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 201,800 | 200,400 | 199,700 | 264,000 | 173,800 |
| Other current liabilities | 431,700 | 401,600 | 386,500 | 506,600 | 445,500 |
| TOTAL | $824,000 | $1,045,700 | $778,200 | $1,250,700 | $908,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,034,600 | 2,032,600 | 2,022,800 | 2,024,900 | 2,225,200 |
| aiOther Non-Current Liabilities | 323,700 | 328,500 | 341,300 | 338,300 | 332,900 |
| TOTAL | $2,810,600 | $2,803,000 | $2,804,800 | $2,816,200 | $3,020,800 |
| Total Liabilities | $3,634,600 | $3,848,700 | $3,583,000 | $4,066,900 | $3,929,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 163,069 | 161,916 | 160,889 | 160,327 | 159,113 |
| Common Shares | 734,000 | 734,000 | 734,000 | 734,000 | 734,000 |
| Retained earnings | 6,249,100 | 6,237,700 | 6,217,800 | 6,136,800 | 6,046,200 |
| Other shareholders' equity | -206,500 | -289,800 | -239,100 | -186,300 | -196,700 |
| TOTAL | $4,875,400 | $4,715,000 | $4,678,200 | $4,609,200 | $4,475,400 |
| Total Liabilities And Equity | $8,510,000 | $8,563,700 | $8,261,200 | $8,676,100 | $8,404,700 |